Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,715 total articles
Amesite Inc. has entered into a private placement agreement with company insiders to raise approximately $600,000 by selling common stock and warrants priced at a premium to market. This follows a concurrent registered direct offering and aims to help the company regain compliance with Nasdaq's minimum stockholder equity requirements, with total gr…
Cabaletta Bio and Cellares have entered a 10-year commercial supply agreement to leverage Cellares' automated Cell Shuttle and Cell Q platforms for the industrial manufacturing of rese-cel, a CAR T cell therapy targeting autoimmune diseases. This partnership aims to enable flexible, scalable, and cost-efficient production to supply thousands of pat…
Aterian, Inc. announced a definitive agreement to sell its marquee e-commerce brand portfolio to Trademark Global for $18 million, subject to adjustments, and a separate $7 million strategic investment via convertible preferred stock by David Lazar, who will become CEO after closing. The sale requires stockholder approval and is expected to close i…
Annovis Bio released peer-reviewed Phase 2/3 trial data of their oral therapy buntanetap in mild to moderate Alzheimer's disease patients. The drug demonstrated dose-dependent cognitive improvements, reduced neurotoxic and neuroinflammation biomarkers, and was safe and well-tolerated, including in genetically at-risk ApoE4 carriers. These results s…
California BanCorp reported net income of $13.8 million ($0.42 per diluted share) for the first quarter of 2026, down from $16.4 million in Q4 2025. The company highlighted benefits from a merger driving a statewide footprint in California's key markets. Despite a slight increase in net interest margin to 4.47%, the company experienced a decrease i…
BIO-key International, Inc. announced a 1-for-10 reverse stock split effective April 30, 2026, approved by stockholders to help meet Nasdaq's minimum bid price requirements. The company aims to position its stock for compliance while targeting profitability in the first half of 2026. BIO-key develops biometric identity and access management solutio…
Nexera Technologies Ltd announced that its subsidiary KeepZone AI has received official authorization from a protective infrastructure provider to introduce and represent an advanced composite structural survivability system for fuel storage tanks and critical energy infrastructure in the Gulf. This system enhances blast mitigation, fragmentation p…
InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapies, has announced that it has regained compliance with Nasdaq's minimum bid price requirement after its ordinary shares closed at or above $1.00 for 10 consecutive business days. This compliance removes the risk of delisting and bolsters confidence in the company's stock.
Watsco, Inc., the largest North American HVAC/R distributor, announced a definitive agreement to acquire Jackson Supply Company, a leading HVAC distributor in the Sunbelt region with $230 million in revenue and 25 locations. The acquisition is expected to close in Q2 2026, enhancing Watsco's scale in high-growth markets and leveraging technology pl…
ZenaTech, Inc. (Nasdaq: ZENA) announced that its subsidiary ZenaDrone will showcase its most comprehensive defense-focused drone hardware, software, and Drone as a Service (DaaS) at the AUVSI Xponential 2026 conference in Detroit. The company will engage defense, government, and enterprise stakeholders with live demonstrations, a podcast studio, an…
Harvard Bioscience, a life sciences technology developer, declared that it will release quarterly financial results for Q1 2026 on May 12 before market open and host a conference call to discuss these results. The company provides technologies and services supporting research and pharmaceutical development globally, with operations in the US, Europ…
NorthStrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced the filing of a new US patent application covering the development of EL-22, a myostatin-engineered probiotic technology, for pharmaceutical use targeting muscle loss conditions in humans. The patent includes protection for specific dosing regimens and formul…
Streamex Corp. (NASDAQ: STEX) announced the first yield distribution for GLDY, a gold-backed, yield-bearing tokenized security. The yield, generated through a gold leasing program with an annualized lease yield of 3.5%, is distributed in additional GLDY tokens monthly. This milestone validates Streamex's infrastructure and product, bridging traditi…
Watsco, Inc., the leading North American HVAC distributor, reported flat first quarter 2026 revenues and earnings, reflecting market stabilization following the A2L refrigerant transition. The company announced the pending acquisition of Jackson Supply Company, enhancing scale and diversification in its core Sunbelt markets. Watsco continues to inv…
Helus Pharma has partnered with mental health organization TARA Mind to support recruitment for its Phase 3 clinical trial of HLP003, a novel serotonergic agonist for major depressive disorder, specifically targeting veterans. This collaboration aligns with a recent U.S. Executive Order focusing on accelerating treatments for serious mental illness…
BridgeBio Pharma initiates a national educational campaign highlighting ATTR-CM, a frequently overlooked heart condition, to encourage earlier diagnosis and treatment. The campaign features advocates Morgan Freeman and Howard H. White and promotes their drug, Attruby®, which showed significant clinical benefits in reducing cardiovascular-related ho…
FTI Consulting's economic consulting arm, Compass Lexecon, has announced the affiliation of Dr. Ori Heffetz, a prominent behavioral and experimental economist with distinguished academic credentials. Dr. Heffetz brings expertise in applied economics, behavioral research, survey methodology, and experimental economics, aligning with Compass Lexecon'…
Cytokinetics announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress, focusing largely on its cardiac myosin inhibitor MYQORZO® (aficamten), recently approved in major markets including the US, Europe, and China for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The presentations will highlight cl…
3D Systems announced that its NextDent Jet Base and Jet Teeth materials, along with the NextDent 300 MultiJet 3D printer, have achieved Class IIa certification under the EU Medical Device Regulation. This certification allows the immediate commercial launch of its flagship jetted denture solution across Europe two months ahead of schedule, signific…
Keel Infrastructure Corp., a North American digital and energy infrastructure company specializing in data centers and energy solutions for high-performance computing and AI workloads, announced its participation in Needham’s Annual Technology, Media, & Consumer Conference in New York City on May 12-13, 2026. The company will deliver a management p…
SL Green Realty Corp., Manhattan's largest office landlord, has secured the asset management assignment for 15 Laight Street, a newly constructed 109,000 square foot boutique office building owned by Hyundai Motor Group. SL Green's third-party asset management platform will provide comprehensive leasing and management services, targeting creative, …
Wave Life Sciences Ltd. announced Q1 2026 financial results showing improved net loss compared to prior year and significant cash reserves to fund operations through Q3 2028. The company reported key clinical progress including FDA acceptance to initiate the Phase 2a trial of WVE-007 for obesity, upcoming data presentations from the AATD-targeted W…
Kiniksa Pharmaceuticals reported robust Q1 2026 financial results, highlighted by a 56% year-over-year growth in ARCALYST net product revenue totaling $214.3 million. The company raised its 2026 ARCALYST revenue guidance to $930-$945 million. Pipeline progress includes expected Phase 2 data for KPL-387 in recurrent pericarditis in H2 2026, with Pha…
Plus Therapeutics announced a new coverage agreement with Blue Shield of California for its CNSide® cerebrospinal fluid tumor cell assay, a diagnostic tool for metastatic CNS cancers. This agreement increases total covered lives from 75 million to 81 million, supporting the company's goal of 150 million by 2026 and enhancing adoption by reducing re…
Aveanna Healthcare Holdings Inc. announced its participation in the Barclays 30th Annual Leveraged Finance Conference, where its management will conduct investor meetings. The company provides a range of pediatric and adult healthcare services across 38 states, focusing on cost-effective care alternatives to hospitalization.
